124 related articles for article (PubMed ID: 38651500)
1. Identification of the characteristics and prognostic impact of FUS::ERG and RUNX1::CBFA2T3 fusion genes in adult acute myeloid leukemia patients.
Zhou Z; Zhuo N; Zhou Y; Sun C; Yao Y; Mao L; Zhang Y; Hong Q; Pan P; Tong H; Jin J; Wang H
Am J Hematol; 2024 Jul; 99(7):1441-1444. PubMed ID: 38651500
[No Abstract] [Full Text] [Related]
2. Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group.
Noort S; Zimmermann M; Reinhardt D; Cuccuini W; Pigazzi M; Smith J; Ries RE; Alonzo TA; Hirsch B; Tomizawa D; Locatelli F; Gruber TA; Raimondi S; Sonneveld E; Cheuk DK; Dworzak M; Stary J; Abrahamsson J; Arad-Cohen N; Czogala M; De Moerloose B; Hasle H; Meshinchi S; van den Heuvel-Eibrink M; Zwaan CM
Blood; 2018 Oct; 132(15):1584-1592. PubMed ID: 30150206
[TBL] [Abstract][Full Text] [Related]
3. RNA-sequencing analysis of core binding factor AML identifies recurrent ZBTB7A mutations and defines RUNX1-CBFA2T3 fusion signature.
Lavallée VP; Lemieux S; Boucher G; Gendron P; Boivin I; Armstrong RN; Sauvageau G; Hébert J
Blood; 2016 May; 127(20):2498-501. PubMed ID: 26968532
[No Abstract] [Full Text] [Related]
4. Myeloid translocation gene CBFA2T3 directs a relapse gene program and determines patient-specific outcomes in AML.
Steinauer N; Guo C; Huang C; Wong M; Tu Y; Freter CE; Zhang J
Blood Adv; 2019 May; 3(9):1379-1393. PubMed ID: 31040112
[TBL] [Abstract][Full Text] [Related]
5. Identification of a potential "hotspot" DNA region in the RUNX1 gene targeted by mitoxantrone in therapy-related acute myeloid leukemia with t(16;21) translocation.
Ottone T; Hasan SK; Montefusco E; Curzi P; Mays AN; Chessa L; Ferrari A; Conte E; Noguera NI; Lavorgna S; Ammatuna E; Divona M; Bovetti K; Amadori S; Grimwade D; Lo-Coco F
Genes Chromosomes Cancer; 2009 Mar; 48(3):213-21. PubMed ID: 19023877
[TBL] [Abstract][Full Text] [Related]
6. ASXL genes and RUNX1: an intimate connection?
Metzeler KH
Blood; 2014 Aug; 124(9):1382-3. PubMed ID: 25170110
[TBL] [Abstract][Full Text] [Related]
7. Detection of rare reciprocal RUNX1 rearrangements by next-generation sequencing in acute myeloid leukemia.
Flach J; Shumilov E; Joncourt R; Porret N; Tchinda J; Legros M; Scarpelli I; Hewer E; Novak U; Schoumans J; Bacher U; Pabst T
Genes Chromosomes Cancer; 2020 Apr; 59(4):268-274. PubMed ID: 31756777
[TBL] [Abstract][Full Text] [Related]
8. The oncofusion protein FUS-ERG targets key hematopoietic regulators and modulates the all-trans retinoic acid signaling pathway in t(16;21) acute myeloid leukemia.
Sotoca AM; Prange KH; Reijnders B; Mandoli A; Nguyen LN; Stunnenberg HG; Martens JH
Oncogene; 2016 Apr; 35(15):1965-76. PubMed ID: 26148230
[TBL] [Abstract][Full Text] [Related]
9. RUNX1 mutation associated with clonal evolution in relapsed pediatric acute myeloid leukemia with t(16;21)(p11;q22).
Ismael O; Shimada A; Elmahdi S; Elshazley M; Muramatsu H; Hama A; Takahashi Y; Yamada M; Yamashita Y; Horide K; Kojima S
Int J Hematol; 2014 Feb; 99(2):169-74. PubMed ID: 24374719
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel fusion gene, RUNX1-PRPF38A, in acute myeloid leukemia.
Wang H; Chen X; Xu Z; Tan Y; Qi X; Zhang L; Xu A; Ren F
Int J Lab Hematol; 2017 Aug; 39(4):e90-e93. PubMed ID: 28263028
[No Abstract] [Full Text] [Related]
11. Cryptic FUS-ERG fusion identified by RNA-sequencing in childhood acute myeloid leukemia.
Panagopoulos I; Gorunova L; Zeller B; Tierens A; Heim S
Oncol Rep; 2013 Dec; 30(6):2587-92. PubMed ID: 24068373
[TBL] [Abstract][Full Text] [Related]
12. Myeloid neoplasms with t(16;21)(q24;q22)/RUNX1-RUNX1T3 mimics acute myeloid leukemia with RUNX1-RUNX1T1.
Liu H; Wang SA; Schlette EJ; Xu J; Jorgensen JL; Cameron Yin C; Li S; Jeffrey Medeiros L; Tang G
Ann Hematol; 2018 Oct; 97(10):1775-1783. PubMed ID: 29872884
[TBL] [Abstract][Full Text] [Related]
13. High number of additional genetic lesions in acute myeloid leukemia with t(8;21)/RUNX1-RUNX1T1: frequency and impact on clinical outcome.
Krauth MT; Eder C; Alpermann T; Bacher U; Nadarajah N; Kern W; Haferlach C; Haferlach T; Schnittger S
Leukemia; 2014 Jul; 28(7):1449-58. PubMed ID: 24402164
[TBL] [Abstract][Full Text] [Related]
14. Relapsed RUNX1-RUNX1T1-positive acute myeloid leukemia with pseudo-Chediak-Higashi granules.
Kondo H; Kanayama T; Matsumura U; Urata T; Osone S; Imamura T; Inaba T; Hosoi H
Int J Hematol; 2021 May; 113(5):616-617. PubMed ID: 33782817
[No Abstract] [Full Text] [Related]
15. Detection of FUS-ERG chimeric transcript in two cases of acute myeloid leukemia with t(16;21)(p11.2;q22) with unusual characteristics.
Kim J; Park TS; Song J; Lee KA; Hong DJ; Min YH; Cheong JW; Choi JR
Cancer Genet Cytogenet; 2009 Oct; 194(2):111-8. PubMed ID: 19781443
[TBL] [Abstract][Full Text] [Related]
16. RUNX1-MTG16 fusion gene in de novo acute myeloblastic leukemia with t(16;21)(q24;q22).
Athanasiadou A; Stalika E; Sidi V; Papaioannou M; Gaitatzi M; Anagnostopoulos A
Leuk Lymphoma; 2011 Jan; 52(1):145-7. PubMed ID: 21054152
[No Abstract] [Full Text] [Related]
17. Molecular characteristic of acute leukemias with t(16;21)/FUS-ERG.
Zerkalenkova E; Panfyorova A; Kazakova A; Baryshev P; Shelihova L; Kalinina I; Novichkova G; Maschan M; Maschan A; Olshanskaya Y
Ann Hematol; 2018 Jun; 97(6):977-988. PubMed ID: 29427188
[TBL] [Abstract][Full Text] [Related]
18. Core binding factor acute myeloid leukemia: the impact of age, leukocyte count, molecular findings, and minimal residual disease.
Hoyos M; Nomdedeu JF; Esteve J; Duarte R; Ribera JM; Llorente A; Escoda L; Bueno J; Tormo M; Gallardo D; de Llano MPQ; Martí JM; Aventín A; Mangues R; Brunet S; Sierra J
Eur J Haematol; 2013 Sep; 91(3):209-218. PubMed ID: 23646898
[TBL] [Abstract][Full Text] [Related]
19. TLS/FUS-ERG fusion gene in acute leukemia and myelodysplastic syndrome evolved to acute leukemia: report of six cases and a literature review.
Zhang H; Zhan Q; Wang X; Gao F; Yu J; Wang J; Fu W; Wang P; Wei X; Zhang L
Ann Hematol; 2022 Dec; 101(12):2583-2600. PubMed ID: 36181538
[TBL] [Abstract][Full Text] [Related]
20. First Case of
Jeon SJ; Park JH; Lim H; Won EJ; Choi H; Choi HJ; Kee SJ; Kim SH; Shin JH; Shin MG
Ann Lab Med; 2023 Jan; 43(1):92-95. PubMed ID: 36045062
[No Abstract] [Full Text] [Related]
[Next] [New Search]
